Rapacuroniumbromide , ≥98% , 156137-99-4
| Pack Size | Price | Stock | Quantity |
| 5mg | RMB3192.00 | In Stock |
|
| 10mg | RMB5016.00 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Melting point: | 184° |
| alpha | 20D -12.7° (c = 1.01 in CHCl3) |
| storage temp. | Store at -20°C |
| solubility | DMSO : ≥ 125 mg/mL (184.42 mM) |
| form | Solid |
| color | Light yellow to yellow |
Description and Uses
Rapacuronium bromide was introduced in the US as a parenterally administered adjunct to general anesthesia during surgical procedures. It is a new steroidal derivative belonging to the same class as vecuronium bromide. This 2,16-bispiperidinylandrostane derivative can be synthesized in 3 steps from the 3-hydroxy-androstan-17-one analog and finally quaternized with allyl bromide. Rapacuronium bromide is a nondepolarizing neuromuscular blocking drug with a rapid onset and a short duration of action. With a relatively low potency (ED90 = 1.15 mg/kg), Rapacuronium is expected to be substituted for the polarizing succinylcholine with very short duration of action.
Rapacuronium Bromide is an aminosteroidal nondepolarizing neuromuscular blocking agent and was used as a anesthesia.
Safety
| Symbol(GHS) |  GHS06 |
| Signal word | Danger |
| Hazard statements | H302-H312-H331 |
| Precautionary statements | P264-P270-P301+P312-P330-P501-P280-P302+P352-P312-P322-P363-P501-P261-P271-P304+P340-P311-P321-P403+P233-P405-P501 |
